Skip to main content
IEX
NYSE Technology

IDEX Q2 2026: Sales Climb 6%, EPS Hits $1.93; IEEPA Tariff Refunds Lift Margins

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Industrial Machinery Stocks · Industrial
Sentiment info
Positive
Importance info
7
Price
$229.52
Mkt Cap
$16.988B
52W Low
$157.25
52W High
$243.795
52W Position info
46% above low
Off High info
5.9% below high
Rel. Volume info
2.2× avg
Market data snapshot near publication time

IEX sits 46% above its 52-week low of $157.25 on elevated volume (2.2× avg).

Summary

IDEX posted Q2 2026 net sales of $920.6M (+6% YoY) and diluted EPS of $1.93 (+11%), helped by a $22M IEEPA tariff refund. Organic growth reached 5%, led by Health & Science Technologies.


Key Events · Earnings and Guidance · IEX

  • Q2 Sales and Earnings Beat

    Driven by 5% organic growth, net sales reached $920.6M (+6% YoY) and diluted EPS came in at $1.93 (+11% YoY), surpassing prior-year results.

  • IEEPA Tariff Refund Windfall

    A $22.0M refund of previously paid IEEPA tariffs reduced cost of sales, adding $0.08 to EPS and boosting gross margin by 150 bps.

  • Health & Science Technologies Leads Growth

    Fueled by AI-driven demand in data centers and semiconductors, HST segment sales rose 14% to $414M, with Adjusted EBITDA up 26%.

  • Capital Return to Shareholders

    During H1 2026, IDEX repurchased $151.3M in shares (0.7M shares) and paid $106.7M in dividends, leaving $774.7M remaining under buyback authorization.


Analysis · IEX · Technology

A strong second quarter saw net sales advance 6% to $920.6 million, while diluted EPS rose 11% to $1.93. The performance was amplified by a one-time $22.0 million IEEPA tariff refund that lowered cost of sales, contributing roughly $0.08 to EPS. Organic sales grew 5%, with AI-related demand in data centers and semiconductors propelling the Health & Science Technologies segment. Shareholders received $131 million through buybacks and dividends, and the balance sheet remained robust—$621 million in cash and $530 million available under the revolving credit facility. No material changes to risk factors or critical accounting estimates were disclosed.

How filings like this one have moved

In the 30 days to Oct 5, 2026, 29.2% of the 1496 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.63%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, IEX was trading at $229.52 on NYSE in the Technology sector, with a market capitalization of approximately $17B. The 52-week trading range was $157.25 to $243.80. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

IEX - Latest Insights

IEX
Jul 29, 2026, 8:25 AM EDT
Source: dpa-AFX
Importance Score:
8
Price at Filing: $232.55
Real-time Price: $232.99 info
Change: +$0.440 (+0.19%) info
Market Cap: $17.176B info
IEX
Jul 29, 2026, 7:01 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $232.55
Real-time Price: $232.99 info
Change: +$0.440 (+0.19%) info
Market Cap: $17.176B info
IEX
Apr 29, 2026, 4:33 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $217.34
Real-time Price: $232.99 info
Change: +$15.65 (+7%) info
Market Cap: $17.176B info
IEX
Apr 29, 2026, 7:01 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $215.06
Real-time Price: $232.99 info
Change: +$17.93 (+8%) info
Market Cap: $17.176B info
IEX
Feb 19, 2026, 4:33 PM EST
Filing Type: 10-K
Importance Score:
7
Price at Filing: $207.86
Real-time Price: $232.99 info
Change: +$25.13 (+12%) info
Market Cap: $17.176B info